Veraxa Biotech Holding AG VRXA
NASDAQ VRXA
$1.95 +0.06 (+3.17%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veraxa Biotech Holding AG (VRXA) Receivables - Other (2024)

Veraxa Biotech Holding AG (VRXA) posted quarterly Receivables - Other of -$118895.2 for Q4 2024.

Veraxa Biotech Holding AG (VRXA) Receivables - Other (2024) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has reported Receivables - Other for 1 consecutive years, with -$118895.2 the latest figure, recorded in Q4 2024.

  • In Q4 2024, Receivables - Other changed N/A year-over-year to -$118895.2; the TTM figure through Dec 2024 stood at -$118895.2 (changed N/A YoY), while the FY2025 annual figure was $1.2 million, up 1107.94% from the prior year.
  • Receivables - Other held at -$118895.2 in Q4 2024 per VRXA's latest filing.
  • Across five years, Receivables - Other topped out at -$118895.2 in Q4 2024 and bottomed at -$118895.2 in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2024 -118,895.21
Dec 31, 2024 -118,895.21